株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

麻酔薬の世界市場 (2019~2029年):局所麻酔薬・全身麻酔薬、吸入麻酔薬・静脈麻酔薬・表面麻酔薬、ベンゾカイン・ブピバカイン・リドカイン・プリロカイン・ロピバカイン・デスフルラン・デクスメデトミジン・ミダゾラム・プロポフォール・レミフェンタニル・セボフルラン

Global Anaesthesia Drugs Market 2019-2029: Local, General, Inhalation, Intravenous & Topical, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane

発行 Visiongain Ltd 商品コード 624172
出版日 ページ情報 英文 241 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=146.83円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

Back to Top
麻酔薬の世界市場 (2019~2029年):局所麻酔薬・全身麻酔薬、吸入麻酔薬・静脈麻酔薬・表面麻酔薬、ベンゾカイン・ブピバカイン・リドカイン・プリロカイン・ロピバカイン・デスフルラン・デクスメデトミジン・ミダゾラム・プロポフォール・レミフェンタニル・セボフルラン Global Anaesthesia Drugs Market 2019-2029: Local, General, Inhalation, Intravenous & Topical, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane
出版日: 2019年03月19日 ページ情報: 英文 241 Pages
概要

世界の麻酔薬市場は今後、年間3.9%のCAGR (複合年間成長率) で成長し、2024年に118億米ドルの規模に達する、と予想されています。と予測されています。種類別に見ると、局所麻酔薬のシェアが最も大きくなっています。

当レポートでは、世界の麻酔薬市場について分析し、製品の定義と市場の概況、市場成長の促進・抑制要因、市場規模の動向見通し (今後11年間分)、種類別・投与経路別・地域別の詳細動向、主要企業のプロファイル、といった情報を取りまとめてお届けいたします。

第1章 分析概要

第2章 イントロダクション:麻酔薬について

  • 麻酔とは何か?
    • 麻酔の種類
      • 全身麻酔
      • 局所麻酔
      • 鎮痛作用
  • 麻酔薬のリスクや副作用とは何か?
    • 局所的な副作用
    • 全身への副作用
  • 麻酔薬の分類
  • 肉体的・経済的負担
    • 死亡リスク
    • 疾病リスク
    • 経済的な影響

第3章 世界の麻酔薬市場:概略

第4章 世界の麻酔薬市場の将来予測

第5章 世界の麻酔薬市場の将来予測:種類別

  • 世界の局所麻酔薬市場 (今後11年間分)
  • 世界の全身麻酔薬市場 (今後11年間分)

第6章 世界の麻酔薬市場の将来予測:投与経路別

  • 世界の吸入麻酔薬市場 (今後11年間分)
  • 世界の静脈麻酔薬市場 (今後11年間分)
  • 世界の表面麻酔薬市場 (今後11年間分)

第7章 世界の麻酔薬市場:地域別・国別

  • 麻酔薬市場:地域別
  • 北米市場 (米国、カナダ)
    • 将来予測 (今後11年間分)
    • 将来予測:国別 (今後11年間分)
    • 将来予測:種類別 (今後11年間分)
    • 将来予測:投与経路別 (今後11年間分)
    • 国別分析
  • 欧州市場 (ドイツ、英国、フランス、イタリア、スペインなど)
  • アジア太平洋地域市場 (日本、中国、インドなど)
  • 他の国々の市場 (RoW:ブラジル、メキシコ、ロシア、南アフリカ)

第8章 世界の麻酔薬市場における代表的な医薬品

  • プロポフォール (Diprivan)
  • セボフルラン (Sojourn、Ultane)
  • レミフェンタニル
  • ミダゾラム
  • リドカイン
  • ロピバカイン

第9章 市場の成長促進要因

  • 手術件数の増加
  • 美容外科手術の増加
  • ICD-10コードの指定
  • 全身麻酔薬の需要
  • 研究開発 (R&D) 投資の増大
  • 医療用電源製品の進歩
  • 高齢者人口の増加

第10章 市場の課題

  • 医療市場の再編
  • 厳格な規制ガイドライン
  • 大規模・未来志向・協働型の転帰調査の少なさ

第11章 市場の傾向

  • 最新型技術の進歩
  • 主要企業間の戦略的連携
  • 大手企業の投資拡大に伴う、発展途上国の医療市場の拡大
  • 薬剤送達 (ドラッグデリバリ) 手法の進歩
  • 手術室での麻酔手法を一変させるような新薬の少なさ
  • 麻酔の安全性 (死亡率・疾患率):統計データの改善の見通し
  • 在宅治療の拡大傾向

第12章 パイプライン分子

  • 有望な潜在的パイプライン分子
    • 第IV相分子
      • Exparel (ブピバカインリポソーム)
    • 第III相分子
      • レミマゾラム (CNS 7056)
    • 第I相分子
      • Cyclopropyl-methoxycarbonyl metomidate (ABP-700)
      • Carboetomidate
      • JM-1232 (-) (MR04A3)
      • プロポフォール
      • PF0713
      • フォスプロポフォール
      • AZD-3043 (TD4756)

第13章 世界の麻酔薬市場の代表的企業

  • Baxter International Inc.
  • AbbVie Inc.
  • PAION AG
  • Pfizer Inc.
  • Hameln Pharmaceuticals Ltd.
  • AstraZeneca
  • Fresenius Kabi
  • 丸石製薬
  • Pacira Pharmaceuticals Inc.
  • Hospira Inc. (Pfizer Inc.)
    • 製品ポートフォリオ
    • 昨今の動向 (製品上市、事業提携など)
  • Sandoz International GmbH (Novartis A.G)
  • Piramal Critical Care Inc. (Piramal Group)
  • Mylan N.V.
  • Aurobindo Pharma

第14章 結論

図表

List of Tables

  • Table 2.1: Type of Surgeries performed in 2010 and 2020 (%)
  • Table 5.1: Global Local Anaesthesia Drugs Market 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.2: Global General Anaesthesia Drugs Market 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.1: Global Inhalation Anaesthesia Drugs Market 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.2: Global Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.3: Global Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.1: North America Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.2: U.S. Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.3: Canada Anaesthesia Market Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.4: North America Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.5: North America General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.6v North America Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.7: North America Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.8: North America Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.9: U.S. Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.10: U.S. General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.11: U.S. Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.12: U.S. Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.13: U.S. Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.14: Canada Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.15: Canada General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.16: Canada Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.17: Canada Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.18: Europe Anaesthesia Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.19: Germany Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.20: UK Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.21: France Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.22: Italy Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.23: Spain Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.24: Rest of Europe Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.25: Europe Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.26: Europe General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.27: Europe Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.28: Europe Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.29: Europe Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.30: Germany Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.31: Germany General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.32: Germany Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.33: Germany Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.34: Germany Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.35: UK Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.36: UK General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.37: UK Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.38: UK Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.39: UK Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.40: France Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.41: France General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.42: France Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.43: France Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.44: France Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.45: Italy Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.46: Italy General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.47: Italy Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.48: Italy Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.49: Italy Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.50: Spain Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.51: Spain General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.52: Spain Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.53: Spain Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.54: Spain Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.55: Rest of Europe Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.56: Rest of Europe General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.57: Rest of Europe Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.58: Rest of Europe Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.59: Rest of Europe Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.60: Asia-Pacific Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.61: Japan Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.62: China Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.63: India Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.64: Rest of Asia-Pacific Anaesthesia M Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.65: Asia-Pacific Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.66: Asia-Pacific General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.67: RoW Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.68: RoW Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.69: Brazil Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.70: Brazil General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.71: Brazil Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.72: Brazil Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.73: Brazil Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.74: Mexico Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.75: Mexico General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.76: Mexico Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.77: Mexico Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.78: Mexico Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.79: Russia Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.80: Russia General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.81: Russia Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.82: Russia Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.83: Russia Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.84: South Africa Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.85: South Africa General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.86: South Africa Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.87: South Africa Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.88: South Africa Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%), CAGR (%)
  • Table 12.1: Active Pipeline Molecules under Development for Anaesthesia Drugs
  • Table 13.1: Baxter: Overview
  • Table 13.2: AbbVie: Overview
  • Table 13.3: PAIGON AG: Overview
  • Table 13.4: Pfizer: Overview
  • Table 13.5: Hameln: Overview
  • Table 13.6: AstraZeneca: Overvie
  • Table 13.7: Fresenius Kabi: Overview 2016
  • Table 13.7: Maruishi: Overview
  • Table 13.8: Pacira: Overview

List of Figures

  • Figure 4.1: Global Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 4.2: Global Anaesthesia Market by Region (%), 2016-2028
  • Figure 4.3: Global Anaesthesia Market by Type (%), 2016-2028
  • Figure 4.4: Global Anaesthesia Market by Route of Administration (%), 2016-2028
  • Figure 5.1: Global Local Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 5.2: Global General Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 6.1: Global Inhalation Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 6.2: Global Intravenous Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 6.3: Global Topical Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 7.1: Anaesthesia Drugs Market by Region (% Share), 2016
  • Figure 7.2: Number of Inpatient Surgeries by Type in Canada, 2015-2016
  • Figure 7.3: North America Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 7.4: North America Anaesthesia Drugs Market Forecast by Country 2016-2028: Revenue ($bn)
  • Figure 7.5: North America Anaesthesia Drugs Market by Country: (% Share), 2016
  • Figure 7.6: North America Anaesthesia Drugs Market by Country: (% Share), 2022
  • Figure 7.7: North America Anaesthesia Drugs Market by Country: (% Share), 2028
  • Figure 7.8: North America Anaesthesia Drugs Market Forecast by Type 2016-2028: Revenue ($bn)
  • Figure 7.9: North America Anaesthesia Drugs Market by Type: (% Share), 2016
  • Figure 7.10: North America Anaesthesia Drugs Market by Type: (% Share), 2022
  • Figure 7.11: North America Anaesthesia Drugs Market by Type: (% Share), 2028
  • Figure 7.12: North America Anaesthesia Drugs Market Forecast by Route of Administration 2016-2028: Revenue ($bn)
  • Figure 7.13: North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2016
  • Figure 7.14: North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2022
  • Figure 7.15: North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2028
  • Figure 7.16: Europe Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 7.17: Europe Anaesthesia Drugs Market Forecast by Country 2016-2028: Revenue ($bn)
  • Figure 7.18: Europe Anaesthesia Drugs Market by Country: (% Share), 2016
  • Figure 7.19: Europe Anaesthesia Drugs Market by Country: (% Share), 2022
  • Figure 7.20: Europe Anaesthesia Drugs Market by Country: (% Share), 2028
  • Figure 7.21: Europe Anaesthesia Drugs Market Forecast by Type 2016-2028: Revenue ($bn)
  • Figure 7.22: Europe Anaesthesia Drugs Market by Type: (% Share), 2016
  • Figure 7.23: Europe Anaesthesia Drugs Market by Type: (% Share), 2022
  • Figure 7.24: Europe Anaesthesia Drugs Market by Type: (% Share), 2028
  • Figure 7.25: Europe Anaesthesia Drugs Market Forecast by Route of Administration 2016-2028: Revenue ($bn)
  • Figure 7.26: Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2016
  • Figure 7.27: Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2022
  • Figure 7.28: Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2028
  • Figure 7.29: Asia-Pacific Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 7.30: Asia-Pacific Anaesthesia Drugs Market Forecast by Country 2016-2028: Revenue ($bn)
  • Figure 7.31: Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2016
  • Figure 7.32: Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2022
  • Figure 7.33: Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2028
  • Figure 7.34: Asia-Pacific Anaesthesia Drugs Market Forecast by Type 2016-2028: Revenue ($bn)
  • Figure 7.35: Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2016
  • Figure 7.36: Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2022
  • Figure 7.37: Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2028
  • Figure 7.38: Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration 2016-2028: Revenue ($bn)
  • Figure 7.39: Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2016
  • Figure 7.40: Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2022
  • Figure 7.41: Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2028
  • Figure 7.42: RoW Anaesthesia Drugs Market Forecast 2016-2028: Revenue ($bn), AGR (%)
  • Figure 7.43: RoW Anaesthesia Drugs Market Forecast by Country 2016-2028: Revenue ($bn)
  • Figure 7.44: RoW Anaesthesia Drugs Market by Country: (% Share), 2016
  • Figure 7.45: RoW Anaesthesia Drugs Market by Country: (% Share), 2022
  • Figure 7.46: RoW Anaesthesia Drugs Market by Country: (% Share), 2028
  • Figure 7.47: RoW Anaesthesia Drugs Market Forecast by Type 2016-2028: Revenue ($bn)
  • Figure 7.48: RoW Anaesthesia Drugs Market by Type: (% Share), 2016
  • Figure 7.49: RoW Anaesthesia Drugs Market by Type: (% Share), 2022
  • Figure 7.50: RoW Anaesthesia Drugs Market byType: (% Share), 2028
  • Figure 7.51: RoW Anaesthesia Drugs Market Forecast by Route of Administration 2016-2028: Revenue ($bn)
  • Figure 7.52: RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2016
  • Figure 7.53: RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2022
  • Figure 7.54: RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2028
  • Figure 13.1: Baxter: SWOT Analysis
  • Figure 13.2: AbbVie: SWOT Analysis
  • Figure 13.3: PAION AG: SWOT Analysis
  • Figure 13.4: AstraZeneca: SWOT Analysis
  • Figure 13.5: Fresenius Kabi: SWOT Analysis
  • Figure 13.6: Maruishi Pharmaceuticals: SWOT Analysis
  • Figure 13.7: Pacira Pharmaceuticals: SWOT Analysis
  • Figure 14.1: Anaesthesia market, by type (% share 2016 & 2028)
  • Figure 14.2: Anaesthesia market, by route of administartion (% share 2016 & 2028)

Companies Listed

  • Abbott
  • AbbVie
  • American Cancer Society
  • American Society of Aesthetic Plastic Surgery (ASAPS)
  • American Society of Anesthesiologists (ASA)
  • American Society of Plastic Surgeons
  • AmerisourceBergen Corporation
  • Association of Anaesthetists of Great Britain and Ireland
  • AstraZeneca
  • Aurobindo Pharma Ltd
  • Bactiguard
  • Baxter
  • Cardinal Health, Inc.
  • CDC
  • FDA
  • Fresenius Kabi
  • Hameln Pharmaceuticals GmbH
  • Hameln Pharmaceuticals Ltd.
  • Hameln RDS GmbH
  • Hospira
  • International Society of Aesthetic Plastic Surgery (ISAPS)
  • Janssen
  • Maruishi Pharmaceutical Co
  • Massachusetts General Hospital Department of Anaesthesia
  • McKesson Corporation
  • Multiple Sclerosis Foundation
  • National Institute of Health (NIH)
  • Neon Laboratories Ltd.
  • Novartis
  • Pacira Pharmaceuticals
  • PAION AG
  • Pfizer
  • Piramal
  • Roche
  • Siegfried Group
  • St. Renatus LLC
  • Stemcentrx, Inc.
  • United Nations Narcotics Control Bureau
  • United States Department of Defense
  • United States Department of Veterans Affairs
  • US Census Bureau
  • WHO
目次
Product Code: PHA0358

The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 129 tables and 117 figures- all unavailable elsewhere.

The 241-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Anaesthesia Drugs Market forecasts from 2019-2029
  • Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 for the market segmented by type:
  • Local Anaesthesia Drugs
  • General Anaesthesia Drugs
  • This report also provides revenue forecast to 2029 for these local anaesthesia drugs:
  • Benzocaine
  • Bupivacaine
  • Chloroprocaine
  • Lidocaine
  • Prilocaine
  • Ropivacaine
  • Others
  • This report also provides revenue forecast to 2029 for these general anaesthesia drugs:
  • Desflurane
  • Dexmedetomidine
  • Midazolam
  • Propofol
  • Remifentanil
  • Sevoflurane
  • Others
  • This report shows forecasts to 2029 for the market segmented by route of administration:
  • Inhalation Anaesthesia Drugs
  • Intravenous Anaesthesia Drugs
  • Topical Anaesthesia Drugs
  • Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
  • North America: US and Canada
  • Europe: Germany, UK, France, Italy, Spain, Rest of Europe
  • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
  • RoW: Brazil, Mexico, Russia, South Africa

image1

Each regional and national market is further segmented by type, drug and route of administration.

  • This report discusses these selected leading companies:
  • Baxter International, Inc.
  • AbbVie
  • PAION AG
  • Pfizer
  • Hameln Pharmaceuticals
  • AstraZeneca
  • Fresenius Kabi
  • Maruishi Pharmaceuticals
  • Pacira Pharmaceuticals, Inc

Depending on data availability, we provide for each company: a company overview, financial information, recent development, product portfolio and a SWOT analysis.

  • This report discusses promising drug candidates which are under development for the anaesthesia drugs market.
  • Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.

Visiongain's study is intended for anyone requiring commercial analyses for the anaesthesia drugs market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Why You Should Read This Report
  • 1.2 How This Report Delivers
  • 1.3 Key Questions Answered by This Analytical Report Include:
  • 1.4 Who is This Report For?
  • 1.5 Methodology
    • 1.5.1 Primary Research
    • 1.5.2 Secondary Research
    • 1.5.3 Market Evaluation & Forecasting Methodology
  • 1.6 Frequently Asked Questions (FAQ)
  • 1.7 Associated Visiongain Reports
  • 1.8 About Visiongain

2. Introduction to Anaesthetic Drugs

  • 2.1 What is an Anaesthesia?
    • 2.1.1 Types of Anaesthetics
      • 2.1.1.1 General Anaesthetics
      • 2.1.1.2 Local Anaesthetics
      • 2.1.1.3 Sedation
  • 2.2 What are the Risk and Side Effects of Anaesthesia Drugs?
    • 2.2.1 Localized side effects
    • 2.2.2 General side effects
  • 2.3 Epidemiology of Anaesthetic Drugs
  • 2.4 Humanistic and Economic Burden
    • 2.4.1 Mortality
    • 2.4.2 Morbidity
    • 2.4.3 Economic Impact

3. Introduction to the Global Anaesthesia Drugs Market

4. Global Anaesthesia Drugs Market Forecast 2019-2029

5. Global Anaesthesia Drugs Market Forecast by Type, 2019-2029

  • 5.1 Global Local Anaesthesia Drugs Market 2019-2029
  • 5.2 Global General Anaesthesia Drugs Market 2019-2029

6. Global Anaesthesia Drugs Market Forecast by Routes of Administration, 2019-2029

  • 6.1 Global Inhalation Anaesthesia Drugs Market 2019-2029
  • 6.2 Global Intravenous Anaesthesia Drugs Market 2019-2029
  • 6.3 Global Topical Anaesthesia Drugs Market 2019-2029

7. Global Anaesthesia Drugs by Regional and National Markets, 2019-2029

  • 7.1 Anaesthesia Drugs Market by Region, 2018
  • 7.2 North America Anaesthesia Drugs Market
    • 7.2.1 North America Anaesthesia Drugs Market Forecast 2019-2029
    • 7.2.2 North America Anaesthesia Drugs Market Forecast by Country, 2019-2029
    • 7.2.3 North America Anaesthesia Drugs Market Forecast by Type, 2019-2029
    • 7.2.4 North America Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.2.5 U.S. Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.2.6 Canada Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
  • 7.3 Europe Anaesthesia Drugs Market
    • 7.3.1 Europe Anaesthesia Drugs Market Forecast 2019-2029
    • 7.3.2 Europe Anaesthesia Drugs Market Forecast by Country, 2019-2029
    • 7.3.3 Europe Anaesthesia Drugs Market Forecast by Type, 2019-2029
    • 7.3.4 Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.3.5 Germany Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029
    • 7.3.6 UK Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029
    • 7.3.7 France Anaesthesia Drugs Market by Route of Administration, 2019-2029
    • 7.3.8 Italy Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.3.9 Spain Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.3.10 Rest of Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
  • 7.4 Asia-Pacific Anaesthesia Drugs Market
    • 7.4.1 Asia-Pacific Anaesthesia Drugs Market Forecast 2019-2029
    • 7.4.2 Asia-Pacific Anaesthesia Market Forecast by Country, 2019-2029
    • 7.4.3 Asia-Pacific Anaesthesia Drugs Market Forecast by Type, 2019-2029
    • 7.4.4 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.4.5 Japan Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.4.6 China Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.4.7 India Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.4.8 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
  • 7.5 RoW Anaesthesia Drugs Market
    • 7.5.1 RoW Anaesthesia Drugs Market Forecast 2019-2029
    • 7.5.2 RoW Anaesthesia Drugs Market Forecast by Country, 2019-2029
    • 7.5.3 RoW Anaesthesia Drugs Market Forecast by Type, 2019-2029
    • 7.5.4 RoW Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.5.6 Brazil Anaesthesia Market by Route of Administration, 2019-2029
    • 7.5.7 Mexico Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
    • 7.5.8 Russia Anaesthesia Drugs Market Forecast by Route of Administration, 2017-2029
    • 7.5.9 South Africa Anaesthesia Market Forecast by Route of Administration, 2017-2029

8. Leading Drugs in the Global Anaesthesia Drugs Market, 2018

  • 8.1 Propofol (Diprivan)
  • 8.2 Sevoflurane (Sojourn, Ultane)
  • 8.3 Remifentanil
  • 8.4 Midazolam
  • 8.5 Lidocaine
  • 8.6 Ropivacaine

9. Market Growth Drivers

  • 9.1 Increasing incidence of surgeries
  • 9.2 Increasing cosmetic surgeries
  • 9.3 Designated ICD-10 Code
  • 9.4 Demand for general anaesthesia drugs
  • 9.5 Increased investment in R&D
  • 9.6 Advancements in medical power supply products
  • 9.7 Rise in Geriatric population

10. Market Challenges

  • 10.1 Healthcare consolidation
  • 10.2 Stringent Regulatory Guidelines
  • 10.3 Paucity of large, prospective and collaborative outcome studies

11. Market Trends

  • 11.1 Advances in modern technologies
  • 11.2 Strategic alliances among key players in the market
  • 11.3 Expansion of healthcare sector in developing countries due to growing investments by major players
  • 11.4 Advancements in drug delivery methods
  • 11.5 Paucity of new drugs to change the practice of operating room Anaesthesia
  • 11.6 Expect improved safety statistics regarding anaesthesia mortality and morbidity
  • 11.7 Rising trend of home healthcare

12. Pipeline Molecules

  • 12.1 Promising Potential Pipeline Molecules
    • 12.1.1 Phase IV Molecules
      • 12.1.1.1 Exparel (Bupivacaine Liposome)
    • 12.1.2 Phase III Molecules
      • 12.1.2.1 Remimazolam (CNS 7056)
    • 12.1.3 Phase I Molecules
      • 12.1.3.1 Cyclopropyl-methoxycarbonyl metomidate (ABP-700)
      • 12.1.3.2 Carboetomidate
      • 12.1.3.3 JM-1232 (-) (MR04A3)
      • 12.1.3.4 Propofol
      • 12.1.3.5 PF0713
      • 12.1.3.6 Fospropofol
      • 12.1.3.7 AZD-3043 (TD4756)

13. Leading Companies in Global Anaesthetic Drugs Market, 2018

  • 13.1 Baxter International Inc.
  • 13.2 AbbVie Inc.
  • 13.3 PAION AG
  • 13.4 Pfizer Inc.
  • 13.5 Hameln Pharmaceuticals Ltd.
  • 13.6 AstraZeneca
  • 13.7 Fresenius Kabi
  • 13.8 Maruishi Pharmaceuticals
  • 13.9 Pacira Pharmaceuticals Inc.
  • 13.10 Hospira Inc. (Pfizer Inc.)
    • 13.10.1. Hospira Inc.: Product Portfolio
    • 13.10.2. Recent Developments
      • 13.10.2.1 Sale of Hospira's Medical Devices Business to Enhance Operating Efficiency
      • 13.10.2.2 Pfizer Expands Manufacturing Capacity for Sterile Injectable
  • 13.11 Sandoz International GmbH (Novartis A.G)
    • 13.11.1. Sandoz (Novartis A.G): Product Portfolio
    • 13.11.2. Sandoz (Novartis A.G): Recent Development
      • 13.11.2.1 Launch of First Generic of Suprane, in the U.S. is likely to Foster Market Share
  • 13.12 Piramal Critical Care Inc. (Piramal Group)
    • 13.12.1. Piramal Critical Care Inc. (Piramal Group): Product Portfolio
    • 13.12.2. Piramal Critical Care Inc.: Recent Development
      • 13.12.2.1 Strategic Acquisition to Rapidly Expand Product Offerings
      • 13.12.2.2 Launch of Desflurane in 2019
  • 13.13 Mylan N.V.
    • 13.13.1. Mylan N.V.: Product Portfolio
    • 13.13.2. Mylan N.V.: Recent Development
      • 13.13.2.1 Acquisition China Player to Expand Geographical Reach
  • 13.14 Aurobindo Pharma
    • 13.14.1. Aurobindo Pharma: Product Portfolio
    • 13.14.2. Aurobindo Pharma: Recent Developments
      • 13.14.2.1 ANDA Approval

14. Conclusions

  • Visiongain Report Sales Order Form
  • Associated Visiongain Reports
  • About Visiongain
  • Visiongain report evaluation form

List of Tables

  • Table 2.1 Type of Surgeries performed in 2010 and 2020 (%)
  • Table 4.1 Global Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 4.2 Global Anaesthesia Drugs Market by Regional Market Forecast 2019-2029 ($bn, AGR %, Cumulative)
  • Table 4.3 Global Anaesthesia Drugs Market Forecast by Country 2019-2029 ($bn, AGR %, Cumulative)
  • Table 5.1 Global Local Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.2 Global Local Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.3 Global General Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.4 Global General Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.1 Global Inhalation Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.2 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.3 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.1 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.2 U.S. Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.3 Canada Anaesthesia Market Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.4 North America Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.5 North America Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.6 North America General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.7 North America General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.8 North America Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.9 North America Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.10 North America Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.11 U.S. Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.12 U.S. Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.13 U.S. Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.14 Canada Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.15 Canada Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.16 Canada Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.17 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.18 Germany Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.19 UK Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.20 France Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.21 Italy Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.22 Spain Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.23 Rest of Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.24 Europe General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.25 Europe General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.26 Europe Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.27 Europe Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.28 Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.29 Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.30 Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.31 Germany Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.32 Germany Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.33 Germany Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.34 UK Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.35 UK Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.36 UK Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.37 France Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.38 France Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.39 France Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.40 Italy Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.41 Italy Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.42 Italy Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.43 Spain Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.44 Spain Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.45 Spain Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.46 Rest of Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.47 Rest of Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.48 Rest of Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.49 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.50 Japan Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.51 China Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.52 India Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.53 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.54 Asia-Pacific General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.55 Asia Pacific General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.56 Asia-Pacific Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.57 Asia Pacific Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.58 Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.59 Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.60 Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.61 Japan Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.62 Japan Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.63 Japan Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.64 China Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.65 China Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.66 China Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.67 India Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.68 India Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.69 India Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.70 Rest of Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.71 Rest of Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.72 Rest of Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.73 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.74 Brazil Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.75 Mexico Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.76 Russia Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.77 South Africa Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.78 Rest of RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.79 RoW Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.80 RoW Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.81 RoW General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.82 RoW General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.83 RoW Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.84 RoW Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.85 RoW Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.86 Brazil Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.87 Brazil Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.88 Brazil Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.89 Mexico Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.90 Mexico Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.92 Mexico Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.92 Russia Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.93 Russia Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.94 Russia Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.95 South Africa Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.96 South Africa Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 7.97 South Africa Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 12.1 Active Pipeline Molecules under Development for Anaesthesia Drugs
  • Table 13.1 Baxter: Overview
  • Table 13.2 Baxter: Revenue ($m), Revenue Share (%) and AGR (%) Breakdown by Geographical Segment, 2016-2017
  • Table 13.3 AbbVie: Overview
  • Table 13.4 PAION AG: Overview
  • Table 13.5 Pfizer: Overview
  • Table 13.6 Hameln: Overview
  • Table 13.7 AstraZeneca: Overview
  • Table 13.8 Fresenius Kabi: Overview 2016
  • Table 13.9 Maruishi: Overview
  • Table 13.10 Pacira: Overview
  • Table 13.11 Hospira Inc.: Overview, 2017
  • Table 13.12 Hospira Inc.: Anaesthesia Drug Offerings
  • Table 13.13. Sandoz: Overview, 2017
  • Table 13.14. Sandoz.: Anaesthesia Drug Offerings
  • Table 13.15: Piramal Critical Care Inc.: Overview, 2017
  • Table 13.16. Piramal Critical Care Inc.: Anaesthesia Drug Offerings
  • Table 13.17: Mylan N.V.: Overview, 2017
  • Table 13.18: Mylan N.V..: Anaesthesia Drug Offerings
  • Table 13.19: Aurobindo Pharma: Overview, 2017
  • Table 13.20: Aurobindo Pharma: Anaesthesia Drug Offerings

List of Figures

  • Figure 4.1 Global Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 4.2 Global Anaesthesia Market by Region (%), 2017-2029
  • Figure 4.3 Global Anaesthesia Market by Type (%), 2017-2029
  • Figure 4.4 Global Anaesthesia Market by Route of Administration (%), 2017-2029
  • Figure 5.1 Global Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 5.2 Global Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn)
  • Figure 5.3 Global Local Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 5.4 Global Local Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 5.5 Global Local Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 5.6 Global General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 5.7 Global General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
  • Figure 5.8 Global General Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 5.9 Global General Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 5.10 Global General Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 6.1 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 6.2 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 7.1 Anaesthesia Drugs Market by Region (% Share), 2018
  • Figure 7.2 Number of Inpatient Surgeries by Type in Canada, 2015-2016
  • Figure 7.3 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 7.4 North America Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
  • Figure 7.5 North America Anaesthesia Drugs Market by Country: (% Share), 2018
  • Figure 7.6 North America Anaesthesia Drugs Market by Country: (% Share), 2024
  • Figure 7.7 North America Anaesthesia Drugs Market by Country: (% Share), 2029
  • Figure 7.8 North America Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
  • Figure 7.9 North America Local Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.10 North America Local Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.11 North America Local Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.12 North America General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
  • Figure 7.13 North America General Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.14 North America General Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.15 North America General Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.16 North America Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
  • Figure 7.17 North America Anaesthesia Drugs Market by Type: (% Share), 2018
  • Figure 7.18 North America Anaesthesia Drugs Market by Type: (% Share), 2024
  • Figure 7.19 North America Anaesthesia Drugs Market by Type: (% Share), 2029
  • Figure 7.20 North America Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
  • Figure 7.21 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
  • Figure 7.22 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
  • Figure 7.23 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
  • Figure 7.24 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 7.25 Europe Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
  • Figure 7.26 Europe Anaesthesia Drugs Market by Country: (% Share), 2018
  • Figure 7.27 Europe Anaesthesia Drugs Market by Country: (% Share), 2024
  • Figure 7.28 Europe Anaesthesia Drugs Market by Country: (% Share), 2029
  • Figure 7.29 Europe General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
  • Figure 7.30 Europe General Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.31 Europe General Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.32 Europe General Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.33 Europe Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
  • Figure 7.34 Europe Local Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.35 Europe Local Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.36 Europe Local Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.37 Europe Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
  • Figure 7.38 Europe Anaesthesia Drugs Market by Type: (% Share), 2018
  • Figure 7.39 Europe Anaesthesia Drugs Market by Type: (% Share), 2024
  • Figure 7.40 Europe Anaesthesia Drugs Market by Type: (% Share), 2029
  • Figure 7.41 Europe Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
  • Figure 7.42 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
  • Figure 7.43 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
  • Figure 7.44 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
  • Figure 7.45 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 7.46 Asia-Pacific Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
  • Figure 7.47 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2018
  • Figure 7.48 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2024
  • Figure 7.49 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2029
  • Figure 7.50 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.51 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.52 Asia Pacific General Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.53 Asia Pacific General Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.54 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
  • Figure 7.55 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.56 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.57 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.58 Asia-Pacific Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
  • Figure 7.59 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2018
  • Figure 7.60 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2024
  • Figure 7.61 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2029
  • Figure 7.62 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
  • Figure 7.63 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
  • Figure 7.64 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
  • Figure 7.65 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
  • Figure 7.66 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
  • Figure 7.67 RoW Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
  • Figure 7.68 RoW Anaesthesia Drugs Market by Country: (% Share), 2018
  • Figure 7.69 RoW Anaesthesia Drugs Market by Country: (% Share), 2024
  • Figure 7.70 RoW Anaesthesia Drugs Market by Country: (% Share), 2029
  • Figure 7.71 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.72 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.73 RoW Local Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.74 RoW Local Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.75 RoW General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
  • Figure 7.76 RoW General Anaesthesia Drugs Market by Drug in 2018 (%)
  • Figure 7.77 RoW General Anaesthesia Drugs Market by Drug in 2024 (%)
  • Figure 7.78 RoW General Anaesthesia Drugs Market by Drug in 2029 (%)
  • Figure 7.79 RoW Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
  • Figure 7.80 RoW Anaesthesia Drugs Market by Type: (% Share), 2018
  • Figure 7.81 RoW Anaesthesia Drugs Market by Type: (% Share), 2024
  • Figure 7.82 RoW Anaesthesia Drugs Market by Type: (% Share), 2029
  • Figure 7.83 RoW Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
  • Figure 7.84 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
  • Figure 7.85 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
  • Figure 7.86 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 202
  • Figure 13.1 Baxter: Revenue Share (%) Breakdown by Geographical Segment, 2017
  • Figure 13.2 Baxter: SWOT Analysis
  • Figure 13.3 AbbVie Inc.: Revenue Share (%) Breakdown by Product Segment, 2017
  • Figure 13.4 AbbVie Inc.: Revenue Share (%) Breakdown by Geographic Area, 2017
  • Figure 13.5 AbbVie Inc.: Sevoflurane Drug Revenue Share (%) Breakdown, 2017
  • Figure 13.6 AbbVie: SWOT Analysis
  • Figure 13.7 PAION AG: SWOT Analysis
  • Figure 13.8 AstraZeneca: SWOT Analysis
  • Figure 13.9 Fresenius Kabi: Revenue Share (%) Breakdown by Geographic Area, 2016-2017
  • Figure 13.10 Fresenius Kabi: Revenue Share (%) Breakdown by Product Segment, 2016-2017
  • Figure 13.11 Fresenius Kabi: SWOT Analysis
  • Figure 13.12 Maruishi Pharmaceuticals: SWOT Analysis
  • Figure 13.13 Pacira Pharmaceuticals: SWOT Analysis
  • Figure 14.1 Anaesthesia Market by Type (% share 2019 & 2029)
  • Figure 14.2 Anaesthesia Market by Route of Administration (% share 2019 & 2029)

Companies Listed

  • Abbott
  • AbbVie
  • Alcon
  • AltaSelect S.r.l.
  • AmerisourceBergen Corporation
  • AstraZeneca
  • Aurobindo Pharma Ltd
  • AuroMedics
  • Baxter
  • Cardinal Health, Inc.
  • Fresenius Kabi
  • Hameln Pharmaceuticals GmbH
  • Hameln Pharmaceuticals Ltd.
  • Hameln RDS GmbH
  • Hospira Inc.
  • ICI India Ltd.
  • ICU Medical Inc.
  • Janssen Pharmaceutica NV
  • Jiangsu Hengrui Medicine Co.
  • Maruishi Pharmaceuticals
  • McKesson Corporation
  • McPherson
  • Meda Aktiebolag
  • Minrad Inc.
  • Mylan
  • Neon Laboratories Ltd.
  • Novartis
  • Pacira Pharmaceuticals, Inc.
  • PAION AG
  • Pfizer
  • Piramal Critical Care Inc.
  • Piramal Group
  • Rhodia Organique Ltd.
  • Roche
  • RxElite Inc.
  • Sandoz International GmbH
  • Siegfried Group
  • St. Renatus LLC
  • Stemcentrx, Inc.

List of Other Organizations Mentioned in the Report

  • American Society of Aesthetic Plastic Surgery (ASAPS)
  • American Society of Anesthesiologists
  • American Society of Plastic Surgeons
  • Centers for Disease Control and Prevention (CDC)
  • European Medicines Agency (EMA)
  • Food and Drug Administration (FDA)
  • French Ministry of Health
  • International Narcotics Control Bureau
  • International Society of Aesthetic Plastic Surgery (ISAPS)
  • Japanese Ministry of Health, Labour and Welfare
  • Massachusetts General Hospital
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Multiple Sclerosis Foundation
  • National Central Cancer Registry
  • National Development and Reform Commission (NDRC)
  • United Nations Narcotics Control Bureau
  • United States Department of Defense
  • United States Department of Veterans Affairs
  • US Census Bureau
  • World Health Organization (WHO)
Back to Top